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Dear Editor,

Sulforaphane \[SFN: 1-isothiocyanato-4-(methylsulfinyl)butane\] belongs to the isothiocyanate class of phytochemicals. Glucoraphanin, a glucosinolate precursor of SFN, is a glucosinolate found in cruciferous vegetables such as broccoli, cabbage, cauliflower, and kale. All glucosinolates are composed of a basic structure consisting of a β-D-thioglucose group, a sulfonated oxime group, and an amino acid-derived side chain. Glucosinolates are activated by enzyme-dependent hydrolysis to their respective isothiocyanates. SFN (molecular formula C~6~H~11~NOS~2~) is the biologically active isothiocyanate produced by the metabolism of glucoraphanin by the enzyme myrosinase (Fahey et al., 2015\[[@R11]\]).

SFN is one of the most frequently studied plant-derived isothiocyanate organosulfur compounds. It has been reported to exhibit a wide range of biological effects including antioxidant (Fahey and Talalay, 1999\[[@R10]\]), antimicrobial (Johansson et al., 2008\[[@R19]\]), anticancer (Amjad et al., 2015\[[@R4]\]), anti-inflammatory (Greaney et al., 2016\[[@R14]\]), anti-aging (Sikdar et al., 2016\[[@R45]\]), neuroprotective (Tarozzi et al., 2013\[[@R47]\]), and antidiabetic (Lee et al., 2012\[[@R26]\]).

SFN shows a range of biological activities and health benefits in humans, has been found to be a very promising chemopreventive agent against not only a variety of cancers such as breast, prostate, colon, skin, lung, stomach, and bladder but also against cardiovascular and neurodegenerative diseases and diabetes (Yang et al., 2016\[[@R53]\]). In this present study, we reviewed the most recent studies on the biological and pharmacological activities of SFN (Table 1[(Tab. 1)](#T1){ref-type="fig"}) (References in Table 1: Pal and Konkimalla, 2016\[[@R34]\]; Zhao et al., 2016\[[@R55]\]; Wu et al., 2016\[[@R52]\]; Sasaki et al., 2016\[[@R39]\]; Jiang et al., 2016\[[@R17]\]; Hernández-Rabaza et al., 2016\[[@R15]\]; Sikdar et al., 2016\[[@R45]\]; Li et al., 2016\[[@R28]\]; Thaler et al., 2016\[[@R48]\]; Lan et al., 2016\[[@R23]\]; Shehatou and Suddek, 2016\[[@R42]\]; Townsend and Johnson, 2016\[[@R49]\]; Qi et al., 2016\[[@R37]\]; Abbas et al., 2016\[[@R1]\]; Kikuchi et al., 2015\[[@R21]\]; Atwell et al., 2015\[[@R6]\]; Ma et al., 2015\[[@R30]\]; Kim et al., 2015\[[@R22]\]; Wang et al., 2015\[[@R50]\]; Lubecka-Pietruszewska et al., 2015\[[@R29]\]; Brown et al., 2015\[[@R7]\]; Carrasco-Pozo et al., 2015\[[@R8]\]; Ambrecht et al., 2015\[[@R3]\]; Lavich et al., 2015\[[@R24]\]; Waston et al., 2015\[[@R51]\]; Shirai et al., 2015\[[@R43]\]; Prasad and Mishra, 2015\[[@R36]\]; Li et al., 2015\[[@R27]\]; Cipolla et al., 2015\[[@R9]\]; Angeloni et al., 2015\[[@R5]\]; Oguz et al., 2015\[[@R33]\]; Noh et al., 2015\[[@R32]\]; Shang et al., 2015\[[@R41]\]; Horwacik et al., 2015\[[@R16]\]; Shokeir et al., 2015\[[@R44]\]; Alzoubi et al., 2015\[[@R2]\]; Gabriel et al., 2015\[[@R13]\]; Kee et al., 2015\[[@R20]\]; Rizzo et al., 2014\[[@R38]\]; Pan et al., 2014\[[@R35]\]; Sayed et al., 2014\[[@R40]\]; Singh et al., 2014\[[@R46]\]; Maeda et al., 2014\[[@R31]\]; Zhang et al., 2014\[[@R54]\]; Lee et al., 2014\[[@R25]\]; Fimognari et al., 2014\[[@R12]\]; Jo et al., 2014\[[@R18]\]).
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